Advertisements




Dynavax shares rise 14% on promising cancer conference data

Dynavax Technologies Corp. shares rose 14% in premarket trade Monday after the company released promising data in conjunction with.....»»

Category: topSource: marketwatchApr 16th, 2018

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Brainstorm Health: Facebook Hospital Data, Incyte Stock, Yescarta Price

Brainstorm Health Daily: April 6, 2018 Hello and happy Friday, readers! This is Sy. Shares of biotech Incyte tumbled following a clinical trial setback for one of the company’s marquee experimental cancer.....»»

Category: europeSource: fortuneApr 6th, 2018

For Eleven Biotherapeutics, Cancer Trial Outcomes Could Be "Major Catalyst"

Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a Cambridge, Massachusetts-based developer of targeted protein therapeutics, has been showing promising clinical data for TPT-based cancer treatments. Latest Ratings for.....»»

Category: blogSource: benzingaMar 20th, 2018

The Wall Street Journal: Celgene might buy CAR-T biotech Juno Therapeutics

Juno is one of several companies pioneering a cancer treatment called CAR-T, which is new and very promising......»»

Category: topSource: marketwatchJan 17th, 2018

AstraZeneca"s Lung Cancer Study Data Promising, Shares Spike

AstraZeneca, (AZN) releases data from a late-stage study on Imfinzi which showed that the new cancer drug led to superior progression-free survival to standard of care in lung cancer patients. AstraZeneca, plc A.....»»

Category: worldSource: nytSep 11th, 2017

3 Things In Biotech, April 19: Let"s Talk Genito-Urinary Cancer

3 Things In Biotech, April 19: Let"s Talk Genito-Urinary Cancer.....»»

Category: topSource: seekingalphaApr 20th, 2018

New Global Databank Could Help Treat Rare Cancers and Save Lives Around the World

The Universal Cancer Databank will allow patients with rare cancers to share their data anonymously with researchers and other patients around the world using individual genome sequencing and profiling......»»

Category: topSource: newsweekApr 20th, 2018

3 Things In Biotech, April 17: Lung Cancer Madness

3 Things In Biotech, April 17: Lung Cancer Madness.....»»

Category: topSource: seekingalphaApr 18th, 2018

Aduro Biotech presents data from three programs at AACR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2018

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for that drug. And the larger the drug target group is, the more exciting it........»»

Category: blogSource: 247wallstApr 17th, 2018

Bristol-Myers downgraded on lung cancer data disappointment at Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2018

Merck to move scientists and money toward promising cancer drug

Profits stemming from a Merck & Co. cancer treatment exceeded expectations in 2017. So much so that the Kenilworth, N.J.-based pharma giant will devote more manpower to its development and shed other projects considered less promising. That's ac.....»»

Category: topSource: bizjournalsApr 17th, 2018

Merck Cements Lead in Lung Cancer as Bristol-Myers Fizzles

Merck & Co. might have just shut the door on rival Bristol-Myers Squibb Co. as investors weigh new data that could reshape the treatment of lung cancer, by far the deadliest form of cancer in the U.S......»»

Category: topSource: moneycentralApr 16th, 2018

Nektar shares drop 16% to $84.50 after Bristol-Myers cancer data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)

Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream.  In data presente.....»»

Category: topSource: businessinsiderApr 16th, 2018

Dynavax should be up 35% on "homerun" cancer data, says JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

We"re about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated (MRK, BMS, RHHBY)

Reuters On Monday, three big players in the growing field of cance.....»»

Category: topSource: businessinsiderApr 14th, 2018

Why Clearside Biomedical, Inc. Stock Gained 66.1% March

Promising trial results helped trigger a short squeeze and sent the biotech's shares soaring......»»

Category: topSource: foxnewsApr 13th, 2018

Short Sellers Back Way Off Major Biotechs

The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased......»»

Category: blogSource: 247wallstApr 11th, 2018